“Fitch’s view is that fiscal 2025 may represent a brief operational peak—a period of relative stability afforded by the delay in OBBBA implementation—before a more challenging phase begins,” the ratings agency wrote in a recent report.
Source: www.fiercehealthcare.com
IKON Portfolio Context
Our healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered in Houston, Texas.